International Journal of Frontiers in Medicine, 2026, 8(1); doi: 10.25236/IJFM.2026.080104.
Xue Ren1, Meijia Chen1, Qiuxiang Hu1
1The First Affiliated Hospital of Sun Yat-sen University, Emergency Ward, Guangzhou, 510000, China
This paper summarizes the rescue experience of a patient with stage CNLC Ⅲb hepatocellular carcinoma who developed mid-esophageal fistula complicated with mediastinal vascular rupture and hemorrhage after surgery, and whose bleeding was successfully controlled with a Sengstaken-Blakemore tube after failure of conventional endoscopic hemostasis. Through stepwise decompression and continuous compression with the Sengstaken-Blakemore tube for 14 days, combined with multidisciplinary comprehensive treatment (including respiratory support, anti-infection, and correction of coagulation function), active bleeding was effectively controlled, creating a window period for subsequent treatment. Eventually, the patient was successfully weaned off the ventilator and transferred from the intensive care unit to the general ward after 21 days of hospitalization. This case confirms that the Sengstaken-Blakemore tube can serve as an important bridging therapy for tumor-related esophageal arterial hemorrhage that is inoperable.
Hepatocellular carcinoma; Esophageal fistula; Mediastinal vascular hemorrhage; Sengstaken-Blakemore tube; Hemorrhagic shock; Multidisciplinary treatment
Xue Ren, Meijia Chen, Qiuxiang Hu. Application of Sengstaken-Blakemore Tube in the Management of a Patient with Esophageal Fistula Complicated by Mediastinal Vascular Hemorrhage after Comprehensive Treatment for Hepatocellular Carcinoma. International Journal of Frontiers in Medicine (2026), Vol. 8, Issue 1: 31-34. https://doi.org/10.25236/IJFM.2026.080104.
[1] Tian LL. Effect and Safety of Painless and Conventional Endoscopic Management of Denture Impaction in the Esophagus. Comput Intell Neurosci, 2022, 2022:9949875. doi: 10.1155/2022/9949875.
[2] National Health Commission of the People's Republic of China. Clinical Practice Guidelines for Primary Liver Cancer (2024 Edition). Electron J Integr Oncol, 2024, 10(3):17-68. doi: 10.12290/xhyxzz.2024-0304.
[3] Cao LM, Zhang YX, Liang ZH, et al. Clinical efficacy of different combination therapies with TACE for primary liver cancer complicated with upper gastrointestinal bleeding. J Interv Radiol, 2024, 33(1):33-37.
[4] Zhang YF. Transcatheter embolization for mediastinal hematoma caused by esophageal feeding artery hemorrhage. J Clin Radiol, 2019, 38(2):326-329. doi: 10.13437/j.cnki.jcr.2019.02.036.
[5] Liu B, Li G. Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding. Dis Markers, 2022, 2022:2940578. doi: 10.1155/2022/2940578.
[6] Yao F, Wan R, Li K. Clinical study of Sengstaken-Blakemore tube assisted emergency endoscopic treatment for esophagogastric variceal bleeding. China J Endosc, 2016, 22(8):57-60. doi: 10.3969/j.issn.1007-1989.2016.08.013.
[7] Zhang XY, Ke E, Cao CJ. Research progress of interventional treatment for arterial lower gastrointestinal bleeding. J Interv Radiol, 2021, 30(6):632-635. doi: 10.3969/j.issn.1008-794X.2021.06.024.
[8] Liu YM, et al. Pyogenic liver abscess in non-liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis. Kaohsiung J Med Sci, 2023, 39(1):87-94. doi: 10.1002/kjm2.12613.
[9] Lu GH, et al. Case Report and Literature Review of Multi-drugs Synergy and Targeted Comprehensive Treatment in Advanced Hepatocellular Carcinoma. Curr Cancer Drug Targets, 2024, 24(3):368-374. doi: 10.2174/1568009623666230801093031.
[10] Tu JH, Zhang MQ, Zhao B. Clinical diagnosis and treatment analysis of 141 cases of high-risk acute upper gastrointestinal bleeding. Chin J Emerg Med, 2018, 27(5):518-523. doi: 10.3760/cma.j.issn.1671-0282.2018.05.012.